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Abstract
Background: About 90% of all malaria deaths in sub-Saharan Africa occur in children under five years. Fast and
reliable diagnosis of malaria requires confirmation of the presence of malaria parasites in the blood of patients with
fever or history suggestive of malaria; hence a prompt and accurate diagnosis of malaria is the key to effective
disease management. Confirmation of malaria infection requires the availability of a rapid, sensitive, and specific
testing at an affordable cost. We compared two recent methods (the novel Partec Rapid Malaria Test
® (PT) and the
Binax Now
® Malaria Rapid Diagnostic Test (BN RDT) with the conventional Giemsa stain microscopy (GM) for the
diagnosis of malaria among children in a clinical laboratory of a hospital in a rural endemic area of Ghana.
Methods: Blood samples were collected from 263 children admitted with fever or a history of fever to the
pediatric clinic of the Agogo Presbyterian Hospital. The three different test methods PT, BN RDT and GM were
performed independently by well trained and competent laboratory staff to assess the presence of malaria
parasites. Results were analyzed and compared using GM as the reference standard.
Results: In 107 (40.7%) of 263 study participants, Plasmodium sp. was detected by GM. PT and BN RDT showed
positive results in 111 (42.2%) and 114 (43.4%), respectively. Compared to GM reference standard, the sensitivities
of the PT and BN RDT were 100% (95% CI: 96.6-100) and 97.2% (95% CI: 92.0-99.4), respectively, specificities were
97.4% (95% CI: 93.6-99.3) and 93.6% (95% CI: 88.5-96.9), respectively. There was a strong agreement (kappa)
between the applied test methods (GM vs PT: 0.97; p < 0.001 and GM vs BN RDT: 0.90; p < 0.001). The average
turnaround time per tests was 17 minutes.
Conclusion: In this study two rapid malaria tests, PT and BN RDT, demonstrated a good quality of their
performance compared to conventional GM. Both methods require little training, have short turnaround times, are
applicable as well as affordable and can therefore be considered as alternative diagnostic tools in malaria endemic
areas. The species of Plasmodium cannot be identified.
Background
Half of the world’s population is at risk of malaria, with
an estimated 243 million cases worldwide out of which
85.6% cases occur in Africa [1]. The World Health
Organization (WHO) estimated that 767 000 deaths
occurred in Africa in 2008 of which almost 90% were
children under five years [1]. Prompt parasitological
confirmation by microscopy or alternatively by rapid
diagnostic tests (RDTs) is recommended for all patients
with suspected malaria before treatment is started [1].
This is to prevent the misuse of antimalarial drugs espe-
cially Artemisinin-based combination therapies thereby
preventing the possible development of resistance in the
parasite to these drugs. Treatment solely on the basis of
clinical suspicion should be considered only when para-
sitological diagnosis is not accessible [1]. Thus, it is of
concern that poor diagnostic standards such as the lack
of skilled microscopists and inadequate or absence of
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malaria control.
Another major contributing factor is that the labora-
tory diagnosis of malaria has up to now relied nearly
exclusively on light microscopy which is a valuable tech-
nique when performed correctly but unreliable and was-
teful when poorly executed. A better utilization of
microscopy and the development of alternative diagnos-
tic techniques could substantially improve malaria con-
trol [3]. This study aimed at evaluating and comparing
the novel Partec Rapid Malaria Test
® (PT) (Partec
GmbH, Münster, Germany) and the recently established
Binax Now
® Malaria Rapid Diagnostic Test (BN RDT)
(Binax, Inc., Portland, ME, USA) in malaria diagnosis
among children from an endemic area using Giemsa
stain microscopy as the reference standard. In a first
report we compared PT with GM in a separate collec-
tive of patients using a real time PCR assay as reference
standard [4]. In this study we focused on the assessment
of test result quality and applicability under the field
conditions of a rural hospital laboratory.
Methods
Study site
The study was conducted at the Agogo Presbyterian
Hospital. It is located in the rural Asante Akim North
District of the Ashanti Region of Ghana, West Africa
and is the principal hospital of the district. The district
is located in the eastern part of Ashanti Region and
covers a land area of 1,160 km
2 with an estimated
population of about 142,000 (projection from 2000
Population Census). Over 40% of the population is
under 15 years and over 50% are under 20 years of age.
The microscopically confirmed incidence of malaria in
children under five who reported at the under-five clinic
of the Agogo hospital was 265 per thousand in 2008
(unpublished data, Biostatistics Dept, Agogo Presbyter-
ian Hospital).
Study population
Between June and December 2008 (i.e. from the begin-
ning of the rainy season to the early dry season), 263
cases were enrolled into the study. Samples were
obtained from children attending the pediatric clinic of
the hospital for the first time with fever or a history sug-
gestive of malaria but without previous antimalarial
treatment within two weeks of attending the hospital.
Patients diagnosed with malaria were treated with Arte-
sunate - Amodiaquine or Artemether - Lumefantrine as
second line treatment representing the Ministry of
Health/National Malaria Control Programme approved
Artemisinin-based combination therapy for the treat-
ment of uncomplicated malaria in Ghana.
Ethical Approval
Ethical approval for the study was obtained from the
Committee on Human Research, Publication and Ethics
(CHRPE) of the School of Medical Sciences, KNUST-
Kumasi. After information and appropriate explanations
parents or legal guardians of all participants willing to
participate in the study had to give their consent by
appending their signature or thumbprint to the
informed consent form before any study related proce-
dures were done. Internationally accepted Good Clinical
and Good Laboratory practices were applied in all
procedures.
Sampling
A maximum of 0.5 ml capillary blood was taken from
each child into an EDTA tube labelled with the patient’s
barcode and pathology number. These samples were
examined immediately using the three methods (GM,
BN RDT and PT). All three tests were done immediately
and examined by well-trained and competent laboratory
staff. For GM, the test was examined independently by
two expert microscopists in two different rooms with
each not knowing the result of the other. In the case
where the two microscopic results were discordant, a
third expert reader was employed by an independent
slide coordinator. The result of the third reader was
then considered as the final result. Written results were
communicated immediately to the clinicians.
Giemsa-stained blood film
Thick and thin blood films were prepared using standar-
dized blood volumes of 10 μla n d2μl, respectively.
They were air-dried (thin film was fixed in absolute
methanol), heat fixed and both stained with 10% Giemsa
working solution for 12 minutes. A malaria blood film
was considered negative after 100 high power fields
(HPF) has been examined and no parasite observed. If
parasites were observed, asexual malaria parasites were
counted against 200 white blood cells (WBCs) on the
thick film but all parasites in a final HPF were counted
even if a count of 200 WBCs had been exceeded. The
parasite count per microliter of blood was obtained by
using the formula: (Parasite count/200WBC) × Absolute
WBC count [5]. If parasite density was more than 100
parasites/field in a thick film, the thin film was used for
the count. Upon the observation of asexual malaria
parasites, parasitized red blood cells (RBCs) were
counted against 1,000 RBCs. The parasite count per
microliter of blood was obtained by using the formula:
(Parasite count/1000RBC) × Absolute RBC count [6].
The thin film was used for species identification of
detected malaria parasites. Absolute WBC and RBC
counts were estimated by using the Sysmex KX 21N
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Japan). In addition, gametocytes, schizonts and other
blood parasites, when present, were reported to the clin-
icians. Known positive and negative samples were used
as controls for freshly prepared Giemsa working solu-
tion each day.
Partec Rapid Malaria Test
®
The Partec CyScope
® (Partec GmbH, Münster, Ger-
many) is a microscope that has two light sources: in
addition to the option of normal light microscopy, a
fluorescence light detection through incident UV light
can be applied. It uses readily-prepared and ready to-use
test slides labelled with an unspecific DNA-binding
fluorescent dye (4’-6-Diamidino-2- phenylindole (DAPI);
emission 443 nm) that detects intraerythrocytic Plasmo-
dium DNA [4] resulting in a bright intracellular dot-
shaped fluorescence if the RBCs are infected with
malaria parasites. The test was performed following
manufacturer’s instructions [7]. 5 μl of well mixed capil-
lary blood was placed on the dye labeled area of a slide
with the patients’ pathology number, cover slipped,
incubated at room temperature for a minute and
observed under the 100× objective (oil immersion)
under LED UV light (365 nm). The presence of bright
shiny intracellular tiny dots observed under the UV light
indicated the presence of malaria parasites in erythro-
cytes. To prevent the slides from drying out, they were
k e p ti naw e tc h a m b e r .P a r a s i t e sc o u n t sw e r ed o n ea s
described in the GM method above. If parasite density
was more than 100 parasites/field in a thick film, an
a p p r o x i m a t ec o u n tw a sd o n eb yc o u n t i n gaq u a r t e ro f
the field and multiplying by four to get an approximate
parasite count per field. This figure was used to calcu-
late the parasite density per microliter. Positive and
negative controls were done for each batch of test kits.
Binax Now
® Rapid Diagnostic Test
The BN RDT (Binax, Inc., Portland, ME, USA) is an
immunochromatographic membrane assay that uses
monoclonal antibodies to detect P. falciparum specific
histidine rich protein 2 (HRP-2) and a panmalarial aldo-
lase common to all four human pathogenic species in
venous and capillary blood specimens [8]. This test was
done as described by Wongsrichanalai et al. [9]. 15 μlo f
blood was placed on the purple sample pad; two drops
of test reagent were added to the lower absorbent white
pad located immediately below the sample pad and four
drops to the absorbent white pad up. Lysed blood
wicked up to the base of the upper white absorbent pad
in a few minutes, when the booklet was closed. The
results were read through the viewing window of the
device 15 minutes after closing the window. The pre-
sence or absences of test lines were used to determine
positive and negative results [10] (Table 1). Positive and
negative controls were done for each batch of test kits.
Statistical analysis
Data were double-entered into a predesigned electronic
database using Epi info version 6.04 dfr (Center for Dis-
ease Control, Atlanta, GA, USA) and cleaned regularly.
Data was exported to Stata/SE9.0 statistical software
(Stata Corporation, Texas USA) for analysis. Sensitiv-
ities, specificities, positive predictive and negative pre-
dictive values were determined for the various tests and
compared with one another. A p-value less than 0.05
Table 1 Result interpretation by the Binax Now
® RDT
Positive Test Negative Test Invalid Test
Line Interpretation Line Interpretation Line Interpretation
C plus T1 Positive for C only Negative No Line Invalid test.
P. falciparum only Repeat test with a
new kit.
C plus T2 Positive for T1 or T2 only Invalid test. Repeat
P. vivax or test with a new kit.
P. malariae or
P. ovale or a mix of these. Differentiation of the species is not
possible.
C plus T1 Positive for T1 and T2 only Invalid test. Repeat




P. ovale. Differentiation between a Pf only infection and a mixed
infection containing Pf and
another malaria species is not possible with this test.
Source: Binax NOW
® reagent package insert, 2007 page 6.
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values expressed the agreement beyond chance [11] and
were calculated with a 95% confidence interval. A k-
value of 0.21-0.60, 0.61-0.80 and > 0.80 were considered
as moderate, good and almost perfect agreement beyond
chance respectively. Likelihood ratio tests were included
as performance indices in evaluating the test methods.
Results
Patient recruitment
From June to December 2008 a total of 263 children
(147 males and 116 females) up to 16 years, admitted
w i t hf e v e ro rah i s t o r ys u g g e s t i v eo fm a l a r i aw e r e
included in the study with a mean ± SD age of 7.3 years
±3.4 years (range: 3-16 years).
Giemsa stain microscopy
Overall, GM expert microscopy (Table 2) detected Plas-
modia in 107 blood films (40.7%) with no discordant
readings between the two independent microscopists.
Out of these positive films 105 slides (98.1%) were posi-
tive with mono-infection of P. falciparum (Pf),o fw h i c h
2 slides showed Pf gametocytes in addition to Pf tropho-
zoites, 1 case (0.95%) each was positive with mono-
infection of P. malariae (Pm) and P. ovale (Po), respec-
tively. 156 films (59.3%) were negative of which 2 films
(1.3%) were positive for Pf gametocytes only. The geo-
metric mean parasite count was 631.8 parasites/μl
(range: 50.0 - 8320.0 parasites/μl) with a turnaround
time of 25 minutes per test.
Partec Rapid Malaria Test
®
The Partec Rapid Malaria Test
® revealed 111 slides to be
positive for malaria and 107 slides had concordant results
with GM. Thus 4 results were false positive with a mean
misdiagnosed parasite count of 32.3 parasites/μl, range:
22.0-43.0 parasites/μl. The geometric mean parasite count
was 447.2 parasites/μl (range: 40.0 - 4530.0 parasites/μl)
and significantly lower than that obtained from the GM (p
< 0.001). The turnaround time per test was 5 minutes.
Binax Now
® Malaria Rapid Diagnostic Test
The BN RDT revealed 114 positive test results: 52 tests
showed only two test lines (Table 1: C plus T1)
indicative of P. falciparum mono-infection whilst 52
tests showed all three test lines (Table 1: C plus T1 and
T2) indicative of either P. falciparum only or mixed
infection of P. falciparum and non-P. falciparum species.
There were 10 false positive and 3 false negative results
(Table 2). The BN RDT gave false negative results for
one P. falciparum infection and in the 2 cases of infec-
tion with P. malariae and P. ovale. Test failures, which
were defined as tests that did not show a control band,
were not observed with the BN RDT. The turnaround
time per test was 20 minutes.
Sensitivity and Specificity
Compared to the reference standard, the sensitivities of
the PT and BN RDT were 100% (95% CI: 96.6-100) and
97.2% (95% CI: 92.0-99.4) respectively, and the specifici-
ties were 97.4% (95% CI: 93.6-99.3) and 93.6% (95% CI:
88.5-95.7) respectively (Table 3).
Agreement between PT, BN RDT and GM
Table 3 shows the degree of agreement (kappa), with a
95% confidence interval, observed between the different
test methods. Overall, there was a high degree of agree-
ment between the test methods and the reference
standard.
Discussion
In this study we assessed the field performance of the
PT and BN RDT in a rural Ghanaian hospital laboratory
using conventional Giemsa stain thick and thin blood
films of pediatric specimens as reference standard. Only
few studies in other endemic areas have been conducted
specifically in children so far [12-16]. In one study an
increased sensitivity of a HRP-2 assay in children com-
pared to adults was demonstrated. This was attributed
to lower immunity and possibly less interference by
antibodies [17]. Despite this, there is concern that the
benefits of parasitological confirmation in children
under 5 years may be outweighed by the risks of not
treating children with false negative tests [18].
Studies conducted earlier on BN RDT showed a low
sensitivity (61.5%) for the detection of pure P. malariae
and P. ovale infections [8]. We found false negative
results of BN RDT for only two non-P. falciparum
Table 2 Results of Giemsa stain, Partec Rapid Test
® and Binax Now
® RDT
Positive Negative
Test method Pf only Pm only Po only Mixed Species False Positive Overall Negative False Negative Overall
GM 105* 1 1 - - 107 156
§ - 156
PT
¥ 105 1 1 - 4 111 152 0 152
BN RDT
¥ 52* - - 52 10 114 146 3 149
*2 slides with Trophozoites and Gametocytes
§2 slides with Gametocytes only
¥No Species differenciation
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and Po: 16 parasites/μl) and thus this might be inade-
quate to confirm or refute this point. The BN RDT
however, has been shown to have a very good sensitivity
(100%) for the detection of pure P. falciparum infection
[9]. P. falciparum accounts for almost 99% of malaria
infections in the study area (unpublished data, Biostatis-
tics Dept, Agogo Presbyterian Hospital) and, therefore,
the low sensitivity of the BN RDT for non-P. falciparum
malaria may not be a serious cause for concern in this
area and most parts of sub-Saharan Africa where
malaria infection is predominantly caused by P. falci-
parum [19]. A slight cause for concern might be the
number of steps (about 6 steps) involved in performing
the test as compared to the four-step test of other RDT
formats [20]. However, with adequate training this con-
cern can be addressed. The BN RDT detects the pre-
sence of plasmodial antigens HRP-2 and pan-
Plasmodium aldolase [21]. The detection of 10 false-
positive results could be attributed to one main observa-
tion made in earlier studies. It is well documented that
the HRP-2 antigen can persist up to 28 days after treat-
ment [22,23]. Even though only untreated patients were
enrolled in this study, reliability of information obtained
from mothers/guardians on this might be questionable.
This assumption could have contributed to the
increased numbers of false positive tests. In addition
this assay appears to be an unsuitable tool for monitor-
ing treatment of malaria as previously discussed by
Murray et al [24]. The BN RDT has also been shown to
detect parasite levels > 20 parasites/μlf o rP. falciparum
and ≤ 100 parasites/μlf o rP. vivax [8]. False negative
results could be attributed to the fact that parasite anti-
gen levels were too low to be detected as a result of
very low parasitaemia or by semi-immune parasite car-
riers with low parasitaemia.
Overall the test is simple to perform, rapid (< 15 min-
utes), easy to interpret, requires less training, needs no
laboratory setup and thus it is applicable for field condi-
tions [8,9,21]. The test has also been shown to be heat
stable and performs very well at temperatures up to 45°
C [25]. On the other hand, it has a poor detection rate
for non-P. falciparum infections and has a higher false
positive rate due to the persistence of the antigen target
HRP 2 [8,9,26].
PT uses a fluorescent dye 4’-6-Diamidino-2-phenylin-
dole (DAPI) which detects intracellular double stranded
DNA which is present within Plasmodium-infected ery-
throcytes. The bright shiny dots within infected erythro-
cytes under UV light is extremely characteristic for
malaria and has a very high PPV in areas mainly ende-
mic with P. falciparum [4]. One major limitation of PT
is the disability of specific identification of Plasmodia
and the differentiation of the species. Compared to GM,
PT exhibited four false-positive results which have not
been further investigated. PT could also be more sensi-
tive than GM in detecting low number of parasites [4].
The presence of artifacts such as non-specific aggregated
DAPI, immature erythrocytes or bacterial cells might
have been misinterpreted as plasmodial DNA. The per-
formance characteristics of the tests were very similar as
indicated in their sensitivities, specificities, PPV and
NPV with very good agreements to the GM reference
standard (Table 3). Our study findings correlate well
with the results of a study conducted in Sudan for
adults using the Partec CyScope
® when compared only
with conventional Giemsa stained microscopy [27] as
well as with our first report comparing this malaria test
in another patient’s collective [4]. In this first study we
could attest to the fact that the PT has a high sensitivity
and specificity by referring to the highly sensitive gold
standard RT-PCR which, however, cannot be applied in
field studies in contrast to the PT assay [4]. Both studies
[4,27] confirmed that PT requires very little training and
has a short turnaround time of averagely 5 minutes per
test. In addition our findings regarding PT performance
characteristics and applicability under field conditions
were confirmed by a study conducted in Uganda [28].
This study also underlines the disability of specific iden-
tification and differentiation of Plasmodia species as the
disadvantage of PT. However, the characteristic fluores-
cence of infected erythrocytes has a very high PPV in
areas mainly endemic with P. falciparum.
Thus we value PT analog to GM thick film as a useful
screening method where positive and doubtful results
Table 3 Performance characteristics of two different




(95% CI) (96.6-100) (92.0-99.4)
Specificity 97.4 93.6
(95% CI) (93.6-99.3) (88.5-96.9)
PPV
1 96.4 91.2
(95% CI) (91.0-99.0) (84.5-95.7)
NPV
2 100 98
(95% CI) (97.6-100) (94.2-99.6)
PLR
3 39 15.2
(95% CI) (14.8-103.0) (8.3-27.6)
NLR
4 00
(95% CI) (0.0-0.0) (0.0-0.9)
kappa 0.97 0.9
Std Error 0.06 0.06
p value < 0.001 < 0.001
1 PPV: Positive predictive value
2 NPV: Negative predictive value
3 PLR: Positive likelihood ratio
4 NLR: Negative likelihood ratio
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confirmation and accurate identification of species later.
This strategy takes also into account that Giemsa stain-
ing and microscopy is a very elaborate and challenging
procedure when performed accurately in a high quality
level.
Parasitaemia is used to guide treatment, thus underes-
timation could have significant ramifications for malaria
patients. Parasite counts obtained from PT were signifi-
cantly lower than those obtained from GM. It is unlikely
that parasites are hidden during Giemsa stain micro-
scopy, since adequate preparation of the slide ensures
visibility through all planes of focus. The lysis of the red
blood cells during the staining process reveals the para-
sites and ease the detection [29]. The Partec Rapid
Malaria Test
® employs fluorescence in which red blood
cells are not completely lysed, therefore, they may lie on
each other or overlap with each other thereby prevent-
ing parasites in red blood cells that may be lying
beneath other cells from being identified and counted.
The World Health Organization Sexually Transmitted
Diseases Diagnostics Initiative (SDI) has developed the
A S S U R E Dc r i t e r i aa sab e n c h m a r kt od e c i d ei ft e s t s
address disease control needs: Affordable, Sensitive, Spe-
cific, User-friendly, Rapid and robust, Equipment-free
and Deliverable to end-users [30]. Even though this cri-
teria was developed as a benchmark for the evaluation
of RDTs for sexually transmitted infections such as
syphilis, it can also be used as a benchmark for the eva-
luation of RDTs for other diseases such as malaria
(Table 4). In rural endemic areas where majority of the
people are poor, these tests are affordable enough to be
accessed in the health centers and homes.
The accepted level of sensitivity for a rapid diagnostic
test in diagnosing malaria is a sensitivity of 95% [31].
Compared to the reference standard, both methods were
sensitive and specific enough to be used as diagnostic
tools for the diagnosis of malaria in endemic areas.
Both methods require little training and the BN RDT
can withstand temperatures up to 45°C [25], making it
quite useful for tropical conditions and does not require
any equipment. The PT is battery operated, portable
and can thus be carried for field work and to places
where there may be no regular electricity.
There is the need therefore to expand malaria diag-
nostic services as part of a greater framework of health
system strengthening within resource-limited settings.
Increasingly, countries and implementing partners have
identified that limited diagnostic capacity represents a
major barrier to implementation and sustainability of
prevention, treatment and care programs for malaria
[ 3 2 ] .T h eP Ta n dB NR D T ,t h e r e f o r e ,p r e s e n ta sv e r y
good tools in the prevention, treatment and care pro-
grams for malaria.
Conclusion
In this study we demonstrated comparable and accepta-
ble performance and operational characteristics of PT,
BN RDT and conventional GM with very good agree-
ments with each other. PT and BN RDT require little
training only, have very short turnaround times, are
applicable under field conditions as well as affordable
even in rural areas. Therefore both methods can be con-
sidered as alternative diagnostic tools in malaria ende-
mic areas in addition to or instead of GM.
Recommendations
￿ This study has found the PT to be a reliable diag-
nostic tool that is sensitive and specific in diagnosing
falciparum m a l a r i a .S i n c et h i si st h ep r e d o m i n a n t
species causing most mortality and complications in
Ghana and sub-Saharan Africa, it is relevant and
useful. It is expected that the CyScope
® will show
similar results for other malaria species especially P.
vivax, but this could not be ascertained by this
study. Further studies are needed to determine its
effectiveness in diagnosing other Plasmodium
species.
￿ B a s e do nt h eA S S U R E Dc r i t e r i aa n dt h en e e dt o
expand malaria diagnostic services as part of a
greater framework of health system strengthening
within resource-limited settings [32], the PT and BN
RDT can be considered as a point-of-care diagnostic
device for resource limited endemic areas.
Limitations
￿ In Africa over 70% of malaria cases do not present
initially to health facilities but diagnosed and mana-
ged at home with traditional remedies or drugs
bought from local shops [33]. Patients only attend
health centers after self-treatment fails [34]. This




Affordability $1* $ 0.5*
Sensitivity (%) 96.5 95.6
Specificity (%) 98 96.7
User-friendly 6 steps 3 steps
Rapid and robust Yes Yes
Equipment-free Yes No
Deliverable to end-users Yes Yes
Minimal Training Yes Yes
* Data obtained from the manufacturer
§ $ 1300 price for Partec
® fluorescence microscope (CyScope
®)
Nkrumah et al. BMC Infectious Diseases 2011, 11:143
http://www.biomedcentral.com/1471-2334/11/143
Page 6 of 8might have affected the performance of some of the
test methods especially BN RDT.
￿ The PT is not able to differentiate between Plas-
modium species.
Disclaimer
T h ef i n d i n g sa n dc o n c l u s i o n si nt h i sp a p e ra r et h o s eo f
the authors and do not necessarily represent the views
of any of their affiliated Research Institutions.
Acknowledgements
Financial support for this study was given by a Swiss Foundation. We wish
to thank all patients that took part in this study. We are grateful to the staff
of the Agogo Presbyterian Hospital Laboratory, Agogo, Asante Akim North-
Ghana and Kumasi Centre for Collaborative Research in Tropical Medicine,
Kumasi, Ghana for their support. The work is part of the MPhil thesis of BN.
Author details
1Kumasi Centre for Collaborative Research in Tropical Medicine, Kumasi,
Ghana.
2Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
3Child Health Department, Komfo Anokye Teaching Hospital, Kumasi, Ghana.
4Department of Clinical Microbiology, School of Medical Sciences, Kwame
Nkrumah University of Science and Technology, Kumasi, Ghana.
5Institute for
Transfusion Medicine, Laboratory Medicine and Medical Microbiology,
Dortmund, Germany.
Authors’ contributions
BN designed the study protocol, analyzed the data and headed the writing
of the protocol. JM, NB, ET, YAS and FH planned and initiated the study and
contributed to the writing of the manuscript. SEKA and LI carried out the
tests and also contributed to the writing of the manuscript. SBN contributed
to the analysis of the results and writing of the manuscript. All authors have
read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 12 October 2010 Accepted: 23 May 2011
Published: 23 May 2011
References
1. World Malaria Report. 2009 [http://whqlibdoc.who.int/publications/2009/
9789241563901_eng.PDF].
2. Coleman RE, Maneechai N, Rachaphaew N, Kumpitak C, Miller RS,
Soyseng V, Thimasarn K, Sattabongkot J: Comparison of field and expert
laboratory microscopy for active surveillance for asymptomatic
Plasmodium falciparum and Plasmodium vivax in western Thailand. The
American Journal of Tropical Medicine and Hygiene 2002, 67(2):141-144.
3. Cook GC: Malaria: Obstacles and opportunities. Transactions of the Royal
Society of Tropical Medicine and Hygiene 1992, 86(6):699.
4. Nkrumah B, Agyekum A, Acquah SEK, May J, Tannich E, Brattig N, Nguah SB,
von Thien H, Adu-Sarkodie Y, Huenger F: Comparison of the Novel Partec
Rapid Malaria Test to the Conventional Giemsa Stain and the Gold
Standard Real-Time PCR. Journal of Clinical Microbiology 2010,
48(8):2925-2928.
5. Jeremiah ZA, Uko EK: Comparative analysis of malaria parasite density
using actual and assumed white blood cell counts. Annals of Tropical
Paediatrics 2007, 27(1):75-79.
6. Frean JA: Reliable enumeration of malaria parasites in thick blood films
using digital image analysis. Malaria Journal 2009, 8(1):218.
7. Partec Essential Healthcare. 2007, 9-10[http://www.partec.com/cms/
front_content.php?idcat=39].
8. Farcas GA, Zhong KJY, Lovegrove FE, Graham CM, Kain KC: Evaluation of
the Binax now (r) ict test versus polymerase chain reaction and
microscopy for the detection of malaria in returned travelers. The
American Journal of Tropical Medicine and Hygiene 2003, 69(6):589-592.
9. Wongsrichanalai C, Arevalo I, Laoboonchai A, Yingyuen K, Miller RS,
Magill AJ, Forney J, Gasser RA Jr: Rapid diagnostic devices for malaria:
field evaluation of a new prototype immunochromatographic assay for
the detection of Plasmodium falciparum and non-falciparum
Plasmodium. The American Journal of Tropical Medicine and Hygiene 2003,
69(1):26-30.
10. Inverness Medical: Binax Now® Malaria Test Kit Product Instructions. 2007.
11. Altman DG: Practical statistics for medical research. Boca Raton London
New York Washington, D.C: Chapman and Hall, 1 1991.
12. Tarimo DS, Minjas JN, Bygbjerg IC: Malaria diagnosis and treatment under
the strategy of the integrated management of childhood illness (IMCI):
relevance of laboratory support from the rapid
immunochromatographic tests of ICT Malaria Pf/Pv and OptiMal. Annals
of Tropical Medicine and Parasitology 2001, 95(5):437-444.
13. Singh N, Saxena A, Sharma VP: Usefulness of an inexpensive, Paracheck®
test in detecting asymptomatic infectious reservoir of Plasmodium
falciparum during dry season in an inaccessible terrain in central India.
Journal of Infection 2002, 45(3):165-168.
14. Bojang KA: The diagnosis of Plasmodium falciparum infection in
Gambian children, by field staff using the rapid, manual, ParaSight™-F
test. Annals of Tropical Medicine and Parasitology 1999, 93(7):685-687.
15. Bechem NN, Leke RFG, Tietche F, Taylor DW: Evaluation of a rapid test for
histidine rich protein 2 for diagnosis of Plasmodium falciparum infection
in Cameroonian children. Transactions of the Royal Society of Tropical
Medicine and Hygiene 1999, 93(1):46.
16. Rimon MM, Kheng S, Hoyer S, Thach V, Ly S, Permin AE, Pieche S: Malaria
dipsticks beneficial for IMCI in Cambodia. Tropical Medicine & International
Health 2003, 8(6):536-543.
17. Fryauff DJ, Gomez-Saladin E, Purnomo IS, Sutamihardja MA, Tuti S,
Subianto B, Richie TL: Comparative performance of the ParaSight F test
for detection of Plasmodium falciparum in malaria-immune and
nonimmune populations in Irian Jaya, Indonesia. Bulletin of the World
Health Organization 1997, 75(6):547-552.
18. Interim notes on selection of type of malaria rapid diagnostic test in
relation to the occurrence of different parasite species. [http://www.
wpro.who.int/NR/rdonlyres/CF152D7C-25BA- 49E7-86D2-DBEE4E5B5974/0/
INTERIMNOTESONMALARIARDTS_ RBM_final2_rev3.pdf].
19. World Malaria Report 2010. [http://www.who.int/malaria/
world_malaria_report_2010/malaria2010_summary_keypoints_en.pdf].
20. Ashley EA, Touabi M, Ahrer M, Hutagalung R, Htun K, Luchavez J, Dureza C,
Proux S, Leimanis M, Lwin MM: Evaluation of three parasite lactate
dehydrogenase-based rapid diagnostic tests for the diagnosis of
falciparum and vivax malaria. Malaria Journal 2009, 8(1):241.
21. van den Broek I, Hill O, Gordillo F, Angarita B, Hamade P, Counihan H,
Guthmann JP: Evaluation of three rapid tests for diagnosis of P.
falciparum and P. vivax malaria in Colombia. The American Journal of
Tropical Medicine and Hygiene 2006, 75(6):1209-1215.
22. Humar A, Ohrt C, Harrington MA, Pillai D, Kain KC: Parasight (R) F test
compared with the polymerase chain reaction and microscopy for the
diagnosis of Plasmodium falciparum malaria in travelers. The American
Journal of Tropical Medicine and Hygiene 1997, 56(1):44-48.
23. Laferi H, Kandel K, Pichler H: False positive dipstick test for malaria. New
England Journal of Medicine 1997, 337(22):1635-1636.
24. Murray CK, Bennett JW: Rapid diagnosis of malaria. Interdisciplinary
Perspectives on Infectious Diseases 2009, 2009:1-7.
25. Malaria Rapid Diagnostic Test Performance. Results of WHO product
testing of malaria RDTs: Round 1. [http://www.finddiagnostics.org/
resource-centre/reports_brochures/malaria-diagnostics-report-2009.html].
26. Bell DR, Wilson DW, Martin LB: False-positive results of a Plasmodium
falciparum histidine-rich protein 2-detecting malaria rapid diagnostic
test due to high sensitivity in a community with fluctuating low parasite
density. The American Journal of Tropical Medicine and Hygiene 2005,
73(1):199-203.
27. Hassan S, Okoued SI, Mudathir MA, Malik EM: Testing the sensitivity and
specificity of the fluorescence microscope(Cyscope®) for malaria
diagnosis. Malaria Journal 9(1):88.
28. Sousa-Figueiredo JC, Oguttu D, Adriko M, Besigye F, Nankasi A, Arinaitwe M,
Namukuta A, Betson M, Kabatereine NB, S JR: Investigating portable
fluorescent microscopy (CyScope) as an alternative rapid diagnostic test
for malaria in children and women of child-bearing age. Malaria Journal
2010, 9:245.
Nkrumah et al. BMC Infectious Diseases 2011, 11:143
http://www.biomedcentral.com/1471-2334/11/143
Page 7 of 829. Moody A: Rapid diagnostic tests for malaria parasites. Clinical Microbiology
Reviews 2002, 15(1):66-78.
30. Peeling RW, Holmes KK, Mabey D, Ronald A: Rapid tests for sexually
transmitted infections (STIs): the way forward. Sexually Transmitted
Infections 2006, 82(suppl 5):v1.
31. Towards Quality Testing of Malaria Rapid Diagnostic Tests: Evidence and
Methods. [http://www.wpro.who.int/internet/resources.ashx/RDT/docs/
pdf_version/web3_QARDTreport.pdf].
32. Maputo Declaration 2008. [http://www.who.int/diagnostics_laboratory/
Maputo-Declaration_2008.pdf].
33. Amexo M, Tolhurst R, Barnish G, Bates I: Malaria misdiagnosis: effects on
the poor and vulnerable. The Lancet 2004, 364(9448):1896-1898.
34. Chandramohan D, Jaffar S, Greenwood B: Use of clinical algorithms for
diagnosing malaria1. Tropical Medicine & International Health 2002,
7(1):45-52.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-2334/11/143/prepub
doi:10.1186/1471-2334-11-143
Cite this article as: Nkrumah et al.: Comparative evaluation of two rapid
field tests for malaria diagnosis: Partec Rapid Malaria Test
®® and Binax
Now
®® Malaria Rapid Diagnostic Test. BMC Infectious Diseases 2011
11:143.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Nkrumah et al. BMC Infectious Diseases 2011, 11:143
http://www.biomedcentral.com/1471-2334/11/143
Page 8 of 8